Corrigendum: Peripheral blood lymphocyte subsets predict the efficacy of immune checkpoint inhibitors in non- small cell lung cancer

Front Immunol. 2022 Dec 8:13:1111230. doi: 10.3389/fimmu.2022.1111230. eCollection 2022.

Authors

Kang Miao¹, Xiaotong Zhang¹, Hanping Wang¹, Xiaoyan Si¹, Jun Ni¹, Wei Zhong¹, Jing Zhao¹, Yan Xu¹, Minjiang Chen¹, Ruili Pan¹, Mengzhao Wang¹, Li Zhang¹

Affiliation

¹ Department of Pulmonary and Critical Care Medicine, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China.

Abstract

[This corrects the article DOI: 10.3389/fimmu.2022.912180.].

Keywords: CD4+CD45RA− T cell; CD8+CD38+ T cell; biomarker; immune checkpoint inhibitors (ICIs); lymphocyte subsets.

Copyright © 2022 Miao, Zhang, Wang, Si, Ni, Zhong, Zhao, Xu, Chen, Pan, Wang and Zhang.

Publication types

Published Erratum